Population analysis of Escherichia coli isolates with discordant resistance levels by piperacillin-tazobactam broth microdilution and agar dilution testing

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 3, 2014, Pages 1779-1781

  Shubert, Carole ^a   Slaughter, Jen ^a   Creely, David ^a   Van Belkum, Alex ^a,b   Gayral, Jean Pierre ^a   Dunne, William Michael ^a   Zambardi, Gilles ^a   Shortridge, Dee ^a  

^a BIOMÉRIEUX   (France)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE CIT; BETA LACTAMASE CTX M; BETA LACTAMASE FOX; BETA LACTAMASE OXA 1; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; BETA LACTAMASE TEM 40; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC HETEROGENEITY; INTERMETHOD COMPARISON; MICROBIAL POPULATION DYNAMICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PIPERACILLIN;

EID: 84896822207     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02181-13     Document Type: Article

References (16)

1. Juan C, Conejo MC, Tormo N, Gimeno C, Pascual Á, Oliver A. 2013. Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study. J. Antimicrob. Chemother. 68:619-630. http://dx.doi.org/10.1093/jac/dks439.
2. Traczewski M, Jorgensen J, Wanger A. 2012. Multi-laboratory comparison of three reference methods for determination of piperacillin and piperacillin-tazobactam susceptibility of Gram-negative organisms, poster 2566. Abstr. 112th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
3. Thomson KS, Black J, Moland ES, Reuben J, Wiles T, Brasso W. 2008. Irreproducible piperacillin/tazobactam minimum inhibitory concentrations in microdilution tests with Escherichia coli strains. Int. J. Antimicrob. Agents 31:83-85. http://dx.doi.org/10.1016/j.ijantimicag.2007.08.015. (Pubitemid 350236727)
4. Hung KH, Wang MC, Huang AH, Yan JJ, Wu JJ. 2012. Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii. J. Clin. Microbiol. 50:721-726. http://dx.doi.org/10.1128/JCM.05085-11.
5. Creely D, Zambardi G, van Belkum A, Dunne WM, Jr, Peyret M, Gayral JP, Shortridge D, Shubert C. 2013. International dissemination of Escherichia coli strains with discrepant behavior in phenotypic antimicrobial susceptibility tests. Eur. J. Clin. Microbiol. Infect. Dis. 32:997-1002. http://dx.doi.org/10. 1007/s10096-013-1837-5.
6. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 9th ed. M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; 23rd informational supplement. M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Ikonomidis A, Neou E, Gogou V, Vrioni G, Tsakris A, Pournaras S. 2009. Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii. J. Clin. Microbiol. 47:4055-4059. http://dx.doi.org/10.1128/JCM.00959-09.
9. Tato M, Morosini M, Garcia L, Albertí S, Coque MT, Cantón R. 2010. Carbapenem heteroresistance in VIM-1-producing Klebsiella pneumoniae isolates belonging to the same clone: consequences for routine susceptibility testing. J. Clin. Microbiol. 48:4089-4093. http://dx.doi.org/10.1128/JCM.01130- 10.
10. Perez-Perez FJ, Hanson ND. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162. http://dx.doi.org/10.1128/JCM.40.6.2153-2162.2002. (Pubitemid 34596400)
11. Waltner-Toews R, Paterson D, Qureshi Z, Sidjabat H, Adams-Haduch J, Shutt K, Jones M, Tian G, Pasculle A, Doi Y. 2011. Clinical characteristics of bloodstream infections due to ampicillin-sulbactam resistant, non-extended-spectrum-β-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction. Antimicrob. Agents Chemother. 55:495-501. http://dx.doi.org/10.1128/AAC.00797-10.
12. TEM genes and their relationship to β-lactam resistance. Antimicrob. Agents Chemother. 46:4035-4037. http://dx.doi.org/10.1128/AAC.46.12.4035-4037.2002.
13. Poole K. 2005. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56:20-51. http://dx.doi.org/10.1093/jac/dki171. (Pubitemid 41418335)
14. Webber M, Piddock L. 2003. The importance of efflux pumps in bacterial antibiotic resistance. J. Antimicrob. Chemother. 51:9-11. http://dx.doi.org/10. 1093/jac/dkg050. (Pubitemid 36163821)
15. Reguera J, Baquero F, Perez-Diaz J, Martinez J. 1991. Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coli. J. Antimicrob. Chemother. 27:569-575.
16. Retamar P, López-Cerero L, Muniain MA, Pascual A, Rodríguez-Baño J, ESBL-REIPI/GEIH Group. 2013. Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli. Antimicrob. Agents Chemother. 57:3402-3404. http://dx.doi.org/10.1128/AAC.00135-13.